Femta Pharmaceuticals Announces IND Filing of FM101, a Novel Monoclonal Antibody Targeting IL-6 with Potent Anti-Inflammatory Activity
8/1/2011 8:06:33 AM
More...
|
Formatech, Inc. to Donate Services to Formulate and Fill Femta Pharmaceuticals’ FM101 Monoclonal Antibody under Its "Fillanthropy(TM) Program"
7/30/2010 11:26:28 AM
More...
|
Femta Pharmaceuticals Snags $2.2M for Potent Antibody Drugs
7/14/2010 7:42:52 AM
More...
|
Femta Pharmaceuticals and Lonza Group Ltd. (LZAGY.PK) Enter into Manufacturing Services Agreement and License for Lonza's GS Gene Expression System(TM)
12/15/2009 8:54:03 AM
More...
|